Chennai Meenakshi Hospital sets Sept 30 AGM; book closure starts Sept 24
- Chennai Meenakshi Multispeciality Hospital Ltd schedules its 36th AGM for September 30, 2026
- Book closure for the meeting runs from September 24 to September 30, 2026
- Agenda includes reappointment of MD R. Gomathi and reshuffling of board directors
- Company reported a narrowed net loss of ₹111.72 lakhs in FY26 versus ₹137.37 lakhs in FY25
*this image is generated using AI for illustrative purposes only.
Chennai Meenakshi Multispeciality Hospital Ltd has scheduled its 36th Annual General Meeting (AGM) for September 30, 2026. The company announced that the Register of Members and Share Transfer Books will remain closed from September 24, 2026, to September 30, 2026, to determine eligibility for the meeting.
The AGM will be conducted via video conferencing or other audio-visual means (OAVM) starting at 11:00 am. The cut-off date for determining eligibility to participate in remote e-voting and voting at the AGM is September 23, 2026. Remote e-voting through the Central Depository Services (India) Limited (CDSL) platform will be open from September 27, 2026, at 9:00 am to September 29, 2026, at 5:00 pm.
Key Agenda Items
The notice for the AGM outlines several ordinary and special business resolutions:
- Reappointment of Mrs. R. Gomathi: Shareholders are asked to pass a special resolution to reappoint Mrs. R. Gomathi as Chairman and Managing Director for three years, from November 11, 2026, to November 10, 2029. She will receive a monthly remuneration of ₹1,00,000. As she is over 70 years old, this requires a special resolution under Section 196 of the Companies Act, 2013.
- Reappointment of Mr. Edward M. Prabhakar: An ordinary resolution seeks shareholder approval for the reappointment of Mr. Edward M. Prabhakar as a non-executive director liable to retire by rotation.
- New Director Appointments: The AGM will vote on the appointment of Mr. M. Karunakaran and Mr. R. V. Ramanuja Bharathi as independent directors for five-year terms. Additionally, Mr. A. F. Simeon Telfer and Ms. Sindu Chawla will be appointed as non-executive, non-independent directors.
- Secretarial Auditor: The appointment of Mr. T. Murugan, Practicing Company Secretary, as the Secretarial Auditor for FY27 at a remuneration of ₹60,000 (excluding out-of-pocket expenses and taxes) is also on the agenda.
Board Composition Changes
Effective September 1, 2026, the board redesignated two directors. Mr. A. F. Simeon Telfer and Ms. Sindu Chawla were moved from non-executive independent directors to non-executive non-independent directors. Consequently, they are now liable to retire by rotation. This change aligns with the board’s assessment that it currently has an adequate number of independent directors to meet regulatory requirements and effectively discharge its functions.
Committee Reconstitution
Following the director redesignations, the statutory committees have been reconstituted:
| Committee | Chairman/Chairperson | Members |
|---|---|---|
| Audit Committee | Mr. M. Karunakaran | Mrs. Shama Dhilip, Mrs. Jayanthi Radhakrishnan |
| Nomination and Remuneration | Mrs. Shama Dhilip | Mr. R. V. Ramanuja Bharathi, Mr. Akash Prabhakar |
| Stakeholders' Relationship | Mr. R. V. Ramanuja Bharathi | Mr. M. Karunakaran, Mr. Edward Prabhakar |
Financial Context
The company reported a net loss of ₹111.72 lakhs for FY26, compared to a loss of ₹137.37 lakhs in FY25. Total income rose to ₹3,815.66 lakhs in FY26 from ₹3,567.21 lakhs in the previous year. Management attributes the narrowing loss to operational turnaround initiatives, including cost containment and expansion of high-margin procedures. EBITDA improved to ₹84.21 lakhs in FY26 from ₹64.89 lakhs in FY25.
What the Numbers Show
While top-line revenue grew by approximately 7% year-on-year, the company continues to operate at a net loss. However, the reduction in net loss from ₹137.37 lakhs to ₹111.72 lakhs, coupled with a 30% increase in EBITDA, suggests that operational efficiency measures are beginning to offset high fixed costs. The proposed remuneration for the Managing Director remains modest at ₹12 lakhs per annum, reflecting the company’s current financial constraints and accumulated losses exceeding paid-up capital.
Historical Stock Returns for Chennai Meenakshi Multispeciality
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.03% | -5.89% | -4.26% | +10.91% | -16.03% | +30.75% |
How will the reappointment of Mrs. R. Gomathi as CMD influence the company's strategic roadmap for achieving profitability beyond FY27?
What specific operational initiatives is management planning to implement to convert the improving EBITDA trends into net positive earnings in the near term?
How might the shift of Mr. Telfer and Ms. Chawla from independent to non-independent directors impact investor confidence regarding corporate governance and board independence?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
